Access comprehensive financial analyses and make smarter investments - get
the
Manual of Investments
on Amazon
!
Get
the
Manual of Investments
on Amazon
!
Subscribe
Today
Financial
Technology
Cyclical
Defensive
Healthcare
Energy
Industrials
Real Estate
Materials
Viewpoints
UNITED STATES
PennyMac Financial Announces $650M Senior Notes Offering
2025-02-04
INDUSTRIALS
Berry Global Reports Strong Q1 2025 Results
2025-02-04
KGS
Kodiak Gas Services Declares Dividend and Distribution
2025-02-04
FARM & HEAVY CONSTRUCTION MACHINERY
INDUSTRIALS
PNR
UNITED KINGDOM
Pentair (PNR) Reports Strong Financial Results
Pentair PLC has reported strong financial results for the fourth quarter and full year of 2024. In the fourth quarter of 2024, the company generated sales of $973 million, which was down 1% from the same period in 2023. However, when excluding currency translation, acquisitions, and divestitures, core sales declined by 1% in the fourth quarter of 2024. The company reported operating income of $195 million in the fourth quarter, reflecting a 17% increase compared to the fourth quarter of...
Tuesday, February 04
Market Inference Newsletter
Thanks for Signing Up!
Please enter an email address correctly.
1,true,6,Contact Email,2
TOP STORIES
WEC Energy Group Reports 2024 Net Income Jump
WEC Energy Group (NYSE: WEC) has reported its financial results for the full year of 2024, showcasing a notable increase in net income based on...
IES Reports 18% Revenue Increase in Q1 2025
IES Holdings, Inc. has reported an 18% increase in revenue for the first quarter of fiscal 2025, with revenue reaching $750 million compared to...
OUTFRONT Media Appoints Nick Brien as Interim CEO
Outfront Media Inc. has appointed Nick Brien as the interim Chief Executive Officer, effective February 10, 2025. Brien, who brings a wealth of...
Mineralys Therapeutics Completes Enrollment for Hypertension Trial
Mineralys Therapeutics, Inc. (NASDAQ: MLYS) has announced the completion of enrollment in the explore-CKD phase 2 trial for lorundrostat, a...
Market Trends
CONSUMER STAPLES
UNITED STATES
ADM
ADM Reports $1.8B Net Earnings for 2024
ADM (NYSE: ADM) released its financial results for the fourth quarter and full year ended December 31, 2024. The highlights of the full-year 2024...
Tuesday, February 04
Evolv Technologies Appoints Richard Shapiro as Independent Director
COMPUTER EQUIPMENT
Illumina Stock Decline – What's Next for Investors?
MEDICAL SPECIALITIES
What Is the Market Outlook on CLX?
UNITED STATES
KKR & (KKR) Stock Sees Decline – What's Behind It?
KKR
Analyzing PEP's Decline – Market Perception of the Stock
BEVERAGES
Analyzing MPC's Fundamental Performance
MPC
Fabrinet Releases 10-Q Report, Shares Drop 9.1%
FN
HEALTH CARE
MEDICAL INSTRUMENTS & SUPPLIES
UNITED STATES
Pulse Biosciences Appoints Jon Skinner as CFO
Pulse Biosciences, Inc. has appointed Jon Skinner as its Chief Financial Officer, effective...
Tuesday, February 04
CNH Industrial Reports Decline in Revenues and Net Income
CNH
BKV CFO John T. Jimenez Retires
UNITED STATES
Opal Fuels Appoints Kazi Hasan as CFO
OPAL
ATI Reports Strong Q4 2024 Growth
STEEL
Madison Square Garden Sports Q2 Revenues Up 9%
CONSUMER DISCRETIONARY
Intuitive Machines Redeems Warrants for $0.01
INDUSTRIALS
Amcor Reports Strong Financial Performance
MISCELLANEOUS MANUFACTURING INDUSTRIES
Popular
Carpenter Technology Q2 Operating Income Soars 70%
Uncovering Overlooked Insights on Ferrari (RACE)
Analyzing the Reasons Behind EL's Stock Price Decline
Exploring Centene – A Comprehensive Investor Brief
Unpacking Merck & Co. – Key Stock Insights
Analyzing Market Sentiment Impact on PLTR's Price Surge
PayPal Stock Performance Analysis – Understanding the Numbers
Preminium Access
In Focus
Tuesday, February 04
UBS Stock Plummets – What Caused the Decline Today?
Tuesday, February 04
J&J Snack Foods reports 4.1% sales increase
Tuesday, February 04
Kyndryl Sees $3.74B in Revenues, 5% YoY Decline
Monday, February 03
Vanda and AnaptysBio Strike Global License Deal
Monday, February 03
Apogee Therapeutics Doses First Patient in Phase 2 Trial
Monday, February 03
Entrada Therapeutics Initiates Phase 1/2 Study for Duchenne Muscular Dystrophy
Monday, February 03
Baxter International Appoints New CEO
Monday, February 03
UMB Financial Completes Largest Acquisition in 111-Year History